NYSE:MET - Metlife Stock Price, Forecast & News

$52.61

+0.41 (+0.79 %)

(As of 01/20/2020 03:23 AM ET)

Add

Compare

Today's Range

$52.19

Now: $52.61▼

$52.66

50-Day Range

$48.35

MA: $50.81▼

$52.61

52-Week Range

$41.41

Now: $52.61▼

$52.76

Volume6.08 million shs

Average Volume4.69 million shs

Market Capitalization$48.38 billion

P/E Ratio7.01

Dividend Yield3.37%

Beta1.13

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. Read More…

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Life insurance

Sub-IndustryLife & Health Insurance

SectorFinance

Current SymbolNYSE:MET

Previous Symbol

CUSIP59156R10

CIK1099219

Webhttp://www.metlife.com/

Phone212-578-9500

Debt

Debt-to-Equity Ratio0.21

Current Ratio0.15

Quick Ratio0.15

Price-To-Earnings

Trailing P/E Ratio7.01

Forward P/E Ratio9.51

P/E Growth1

Sales & Book Value

Annual Sales$67.94 billion

Price / Sales0.71

Cash Flow$5.18 per share

Price / Cash Flow10.15

Book Value$53.66 per share

Price / Book0.98

Profitability

EPS (Most Recent Fiscal Year)$5.39

Net Income$5.12 billion

Net Margins10.82%

Return on Equity8.82%

Return on Assets0.75%

Miscellaneous

Employees48,000

Outstanding Shares919,630,000

Market Cap$48.38 billion

Next Earnings Date2/5/2020 (Confirmed)

OptionableOptionable

Receive MET News and Ratings via Email

Sign-up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter.

(Ad)

Simple Options Trading for Beginners retails on Amazon for $19.95 and has 4 out of 5 stars. It was written by a stock market trading veteran with over 44 years of experience. Because of a special promotion, this book is 100% FREE for you today.

Metlife (NYSE:MET) Frequently Asked Questions

What is Metlife's stock symbol?

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

How often does Metlife pay dividends? What is the dividend yield for Metlife?

Metlife announced a quarterly dividend on Tuesday, January 7th. Stockholders of record on Tuesday, February 4th will be paid a dividend of $0.44 per share on Friday, March 13th. This represents a $1.76 dividend on an annualized basis and a dividend yield of 3.35%. The ex-dividend date of this dividend is Monday, February 3rd. View Metlife's Dividend History.

How will Metlife's stock buyback program work?

Metlife declared that its board has authorized a share buyback program on Thursday, November 1st 2018, which allows the company to buyback $2,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to repurchase up to 4.6% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's board of directors believes its shares are undervalued.

How were Metlife's earnings last quarter?

Metlife Inc (NYSE:MET) announced its quarterly earnings results on Wednesday, October, 30th. The financial services provider reported $1.27 EPS for the quarter, missing the Zacks' consensus estimate of $1.40 by $0.13. The financial services provider had revenue of $16.92 billion for the quarter, compared to the consensus estimate of $16.37 billion. Metlife had a return on equity of 8.82% and a net margin of 10.82%. Metlife's revenue for the quarter was up 3.2% on a year-over-year basis. During the same period last year, the company posted $1.38 EPS. View Metlife's Earnings History.

When is Metlife's next earnings date?

Metlife is scheduled to release their next quarterly earnings announcement on Wednesday, February 5th 2020. View Earnings Estimates for Metlife.

How can I listen to Metlife's earnings call?

Metlife will be holding an earnings conference call on Wednesday, February 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What price target have analysts set for MET?

9 brokers have issued 12 month price targets for Metlife's stock. Their forecasts range from $41.00 to $60.00. On average, they expect Metlife's share price to reach $51.00 in the next year. This suggests that the stock has a possible downside of 3.1%. View Analyst Price Targets for Metlife.

What is the consensus analysts' recommendation for Metlife?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 1 sell rating, 4 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Metlife.

What are Wall Street analysts saying about Metlife stock?

Here are some recent quotes from research analysts about Metlife stock:

1. According to Zacks Investment Research, "MetLife’s shares have outperformed its industry, year to date. It has been performing well led by prudent underwriting and expense management. Its efforts to streamline business and focus on core operations are impressive. Acquisitions made by the company will diversify its business and aid inorganic growth. Its disciplined capital deployment is expected to drive long-term growth and create wealth for shareholders. However, its exposure to catastrophe loss remains a concern. Investment in efficiency programs will likely put pressure on margins. Also, the company's net investment income might continue to decline in 2019 due to lower interest rates, which will likely pressurize investment yields." (12/9/2019)
2. Wells Fargo & Co analysts commented, "We do not expect much movement in the shares after our meetings. Our EPS estimates and price target are unchanged. We continue to have an Outperform rating on the shares." (6/5/2019)

Has Metlife been receiving favorable news coverage?

News coverage about MET stock has trended positive this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Metlife earned a news sentiment score of 3.0 on InfoTrie's scale. They also gave news coverage about the financial services provider a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Metlife.

Are investors shorting Metlife?

Metlife saw a increase in short interest during the month of December. As of December 31st, there was short interest totalling 13,310,000 shares, an increase of 35.0% from the December 15th total of 9,860,000 shares. Based on an average daily trading volume, of 4,780,000 shares, the days-to-cover ratio is presently 2.8 days. Approximately 1.7% of the shares of the stock are short sold. View Metlife's Current Options Chain.

Who are some of Metlife's key competitors?

Some companies that are related to Metlife include AFLAC (AFL), Prudential Financial (PRU), Principal Financial Group (PFG), Lincoln National (LNC), Unum Group (UNM), Primerica (PRI), CNO Financial Group (CNO), American Equity Investment Life (AEL), FBL Financial Group (FFG), National Western Life Group (NWLI), Independence (IHC), Citizens (CIA), Kansas City Life Insurance (KCLI) and Health Insurance Innovations (HIIQ).

What other stocks do shareholders of Metlife own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Metlife investors own include AT&T (T), General Electric (GE), IBM (IBM), Pfizer (PFE), Verizon Communications (VZ), Exxon Mobil (XOM), Bank of America (BAC), Intel (INTC), Gilead Sciences (GILD) and Cisco Systems (CSCO).

Who are Metlife's key executives?

Metlife's management team includes the folowing people:

Mr. Michel A. Khalaf, CEO, Pres & Director (Age 55)
Mr. John Dennis McCallion CPA, Exec. VP & CFO (Age 45)
Mr. Steven Jeffrey Goulart, Exec. VP & Chief Investment Officer (Age 60)
Ms. Tamara L. Schock C.A., CPA, Exec. VP & Chief Accounting Officer (Age 47)
Mr. John Arthur Hall, Sr. VP & Head of Investor Relations

Who are Metlife's major shareholders?

Metlife's stock is owned by many different of institutional and retail investors. Top institutional investors include PGGM Investments (0.12%), Wedge Capital Management L L P NC (0.07%), 6 Meridian (0.04%), Alpha Cubed Investments LLC (0.04%), Nisa Investment Advisors LLC (0.03%) and Tocqueville Asset Management L.P. (0.02%). Company insiders that own Metlife stock include Carlos M Gutierrez, Gerald L Hassell, John D Mccallion, Steven A Kandarian and Steven J Goulart. View Institutional Ownership Trends for Metlife.

Which institutional investors are selling Metlife stock?

MET stock was sold by a variety of institutional investors in the last quarter, including Commerzbank Aktiengesellschaft FI, PGGM Investments, DNB Asset Management AS, Nisa Investment Advisors LLC, State of Alaska Department of Revenue, Tocqueville Asset Management L.P., Sciencast Management LP and Abner Herrman & Brock LLC. Company insiders that have sold Metlife company stock in the last year include John D Mccallion and Steven J Goulart. View Insider Buying and Selling for Metlife.

Which institutional investors are buying Metlife stock?

MET stock was bought by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, Diversified Trust Co, BTR Capital Management Inc., Alpha Cubed Investments LLC, Cerebellum GP LLC, Advisors Capital Management LLC, Cullinan Associates Inc. and AE Wealth Management LLC. Company insiders that have bought Metlife stock in the last two years include Carlos M Gutierrez and Gerald L Hassell. View Insider Buying and Selling for Metlife.

How do I buy shares of Metlife?

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Metlife's stock price today?

One share of MET stock can currently be purchased for approximately $52.61.

How big of a company is Metlife?

Metlife has a market capitalization of $48.38 billion and generates $67.94 billion in revenue each year. The financial services provider earns $5.12 billion in net income (profit) each year or $5.39 on an earnings per share basis. Metlife employs 48,000 workers across the globe.View Additional Information About Metlife.

What is Metlife's official website?

The official website for Metlife is http://www.metlife.com/.

How can I contact Metlife?

Metlife's mailing address is 200 PARK AVENUE, NEW YORK NY, 10166. The financial services provider can be reached via phone at 212-578-9500.

MarketBeat Community Rating for Metlife (NYSE MET)

Community Ranking:		3.0 out of 5 ( )
Outperform Votes:		811 (Vote Outperform)
Underperform Votes:		556 (Vote Underperform)
Total Votes:		1,367

MarketBeat's community ratings are surveys of what our community members think about Metlife and other stocks. Vote "Outperform" if you believe MET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MET will underperform the S&P 500 over the long term. You may vote once every thirty days.

This page was last updated on 1/20/2020 by MarketBeat.com Staff